$IOR
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/

2023 Q4 Form 10-Q Financial Statement

#000199937123000059 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $30.00K $440.0K $397.0K
YoY Change -92.99% 10.83% 15.07%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $30.00K $440.0K $397.0K
YoY Change -92.99% 10.83% 15.07%
Operating Profit -$30.00K -$437.0K -$397.0K
YoY Change -92.99% 10.08% 15.07%
Interest Expense $2.910M $2.516M $1.821M
YoY Change 38.84% 38.17% 45.91%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $2.880M $2.080M $1.424M
YoY Change 72.66% 46.07% 57.7%
Income Tax $406.0K $436.0K $236.0K
% Of Pretax Income 14.1% 20.96% 16.57%
Net Earnings $2.474M $1.643M $1.188M
YoY Change 94.96% 38.3% 66.85%
Net Earnings / Revenue
Basic Earnings Per Share $0.60 $0.39 $0.29
Diluted Earnings Per Share $0.60 $0.39 $0.29
COMMON SHARES
Basic Shares Outstanding 4.168M shares 4.168M shares 4.168M shares
Diluted Shares Outstanding 4.168M shares 4.168M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $71.00K $0.00 $11.00K
YoY Change 1083.33% -100.0% -15.38%
Cash & Equivalents $71.00K $12.00K $11.00K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $106.5M $104.8M $99.21M
Other Receivables $106.5M $104.8M $0.00
Total Short-Term Assets $106.9M $105.3M $99.55M
YoY Change 6.04% 5.81% 3.88%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.17M $11.17M $11.17M
YoY Change 0.0% 0.0% -2.93%
TOTAL ASSETS
Total Short-Term Assets $106.9M $105.3M $99.55M
Total Long-Term Assets $11.17M $11.17M $11.17M
Total Assets $118.1M $116.5M $110.7M
YoY Change 5.44% 5.23% 3.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000K $11.00K
YoY Change -90.91% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.00K
YoY Change 0.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $11.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $0.00 $0.00 $11.00K
YoY Change -100.0% -100.0% 0.0%
SHAREHOLDERS EQUITY
Retained Earnings $57.03M $54.55M $48.76M
YoY Change 13.99% 11.89%
Common Stock $62.00M $62.00M $62.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $947.0K $39.00K $39.00K
YoY Change 2328.21% 0.0%
Treasury Stock Shares 5.261K shares
Shareholders Equity $118.1M $116.5M $110.7M
YoY Change
Total Liabilities & Shareholders Equity $118.1M $116.5M $110.7M
YoY Change 5.44% 5.23% 3.15%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $2.474M $1.643M $1.188M
YoY Change 94.96% 38.3% 66.85%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $963.0K $10.00K $10.00K
YoY Change -19360.0% 0.0% -99.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -908.0K
YoY Change
NET CHANGE
Cash From Operating Activities 963.0K 10.00K 10.00K
Cash From Investing Activities 0.000
Cash From Financing Activities -908.0K
Net Change In Cash 55.00K 10.00K 10.00K
YoY Change -1200.0% 0.0% -9.09%
FREE CASH FLOW
Cash From Operating Activities $963.0K $10.00K $10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
dei Entity Central Index Key
EntityCentralIndexKey
0000949961
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14784
dei Entity Registrant Name
EntityRegistrantName
INCOME OPPORTUNITY REALTY INVESTORS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2615944
dei Entity Address Address Line1
EntityAddressAddressLine1
1603 Lyndon B. Johnson Freeway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75234
dei City Area Code
CityAreaCode
(469)
dei Local Phone Number
LocalPhoneNumber
522-4200
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
IOR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4168414 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6000 usd
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
520000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
676000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
104808000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
100134000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
105340000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
100816000 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2023Q3 us-gaap Assets
Assets
116513000 usd
CY2022Q4 us-gaap Assets
Assets
111989000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4168414 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4168414 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5261 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5261 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
39000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
54554000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
50027000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
116512000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116513000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111989000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
91000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
385000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
374000 usd
CY2023Q3 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
346000 usd
CY2022Q3 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
283000 usd
ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
1045000 usd
ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
824000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
437000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
397000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1430000 usd
us-gaap Costs And Expenses
CostsAndExpenses
1198000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-437000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-397000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1430000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1198000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2516000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1821000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
7160000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4506000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
436000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
236000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1203000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
646000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1643000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1188000 usd
us-gaap Net Income Loss
NetIncomeLoss
4527000 usd
us-gaap Net Income Loss
NetIncomeLoss
2662000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
114869000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1643000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
116512000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
109528000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1188000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
110716000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
us-gaap Net Income Loss
NetIncomeLoss
4527000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
116512000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
108054000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
108054000 usd
us-gaap Net Income Loss
NetIncomeLoss
2662000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
110716000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
110716000 usd
us-gaap Net Income Loss
NetIncomeLoss
4527000 usd
us-gaap Net Income Loss
NetIncomeLoss
2662000 usd
us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-156000 usd
us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-253000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
4674000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
2905000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11000 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd

Files In Submission

Name View Source Status
ior-20230930_cal.xml Edgar Link unprocessable
0001999371-23-000059-index-headers.html Edgar Link pending
0001999371-23-000059-index.html Edgar Link pending
0001999371-23-000059.txt Edgar Link pending
0001999371-23-000059-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ior-10q_093023.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ior-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ior-20230930_def.xml Edgar Link unprocessable
ior-20230930_lab.xml Edgar Link unprocessable
ior-20230930_pre.xml Edgar Link unprocessable
ior-10q_093023_htm.xml Edgar Link completed